Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
about
Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activityAntibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpuraPathophysiology of thrombotic thrombocytopenic purpuraVon Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraPathogenesis of thrombotic microangiopathiesHemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimersMolecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage AtherosclerosisADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpuraRelevance of ADAMTS13 to liver transplantation and surgeryShigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.Pernicious Anemia Associated Cobalamin Deficiency and Thrombotic Microangiopathy: Case Report and Review of the LiteratureCurrent understanding of the pathophysiology of thrombotic thrombocytopenic purpura.Control of von Willebrand factor multimer size by thrombospondin-1.A new name in thrombosis, ADAMTS13.HIV associated thrombotic microangiopathy.Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.Systemic antithrombotic effects of ADAMTS13.Thrombotic thrombocytopenic purpura: survival by "giving a dam"ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpuraThe kidney in thrombotic thrombocytopenic purpura.Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes.Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapyPregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.Thrombotic microangiopathies: multimers, metalloprotease, and beyond.A shear-based assay for assessing plasma ADAMTS13 activity and inhibitors in patients with thrombotic thrombocytopenic purpuraThrombotic Thrombocytopenic Purpura associated with Clopidogrel: a case report and review of the literature.Sequential occurrence of thrombotic thrombocytopenic purpura, essential thrombocythemia, and idiopathic thrombocytopenic purpura in a 42-year-old African-American woman: a case report and review of the literature.Thrombotic microangiopathy and associated renal disorders.Two novel heterozygote missense mutations of the ADAMTS13 gene in a child with recurrent thrombotic thrombocytopenic purpuraADAMTS13 deficiency and thrombotic thrombocytopenic purpura associated with trimethoprim-sulfamethoxazoleComplement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathyCharacterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience.A case of congenital TTP presenting with microganiopathy in adulthood.Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study.ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies.Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy: first report from iranModified Ham test for atypical hemolytic uremic syndromeAcquired Thrombotic Thrombocytopenic Purpura in a Patient with Pernicious AnemiaThrombotic Thrombocytopenic Purpura: Pathogenesis, Diagnosis, and Potential Novel Therapeutics.
P2860
Q24535720-8CBF2F2E-53AD-4382-9F35-AF082745A15EQ24614077-86C08F1F-A086-4BC9-80C6-C50308EC32E1Q24614117-55C73271-8550-421F-840C-4A1114DE8E2DQ24651320-AE8CE6E2-BDA7-48B0-808D-43336052234EQ24658043-BF8C4A8F-AA1C-4C56-92E7-4D43787899DDQ24669689-0F81CD7E-5481-4108-B2B8-7688E951BEB7Q27339951-32A46136-BC1D-4EC4-BD4A-20DA7222B5C3Q28083264-3C80C046-B94D-4F3E-B6A3-1AE2B970289BQ28085109-70D730B4-FAC2-451F-8324-C954F8184B71Q28594414-EAA3B24E-3C95-4B4B-A492-9B16DB2A0F9AQ33168354-491B1697-5FCC-44DA-AA1C-DC8FF6B5E50EQ33333785-F7A46153-F0E1-4926-A917-CE110F911773Q33337783-FDC2BD02-B7E3-4E04-8BD6-02DC5B5B6BE4Q33343892-DCE737AE-3852-4B3B-9797-6BAF9864A966Q33344468-006F69FE-D7E9-4A64-A034-43828EA7F1B4Q33369765-FD13C62F-57AE-41E2-BE5D-44DF80907206Q33370540-43F95800-82C6-4133-B063-FFD6DCEF812FQ33373067-A2EBD492-9487-4BF1-8FF5-3BD7E649C44DQ33373698-D9610460-6623-47BD-9A46-E9A695B4A827Q33378755-1121404F-7C2A-4298-A00E-5D7160DD54FCQ33381813-35AB7BDC-2ECA-4BD5-AC03-A7E5D4DDA609Q33382766-B39636BB-2DEF-4981-90F0-843C215981B8Q33388474-FD0D59B8-4B51-462C-89F1-4F554C80CCDAQ33389435-E0D4C048-A55B-4C3F-B142-908CCE0673DFQ33393728-67647205-7AD3-4802-A016-45F9C9FB7131Q33398293-9D250C16-A3EF-44F4-8140-049E67E1348AQ33400532-DA0E4414-BA44-4D30-8780-D0B4A03539EEQ33402372-EFCDB686-8553-491C-A9E7-6C61A9949DDEQ33403769-9A329402-2F2C-4452-BC8E-3CE2CA5F5E4FQ33404941-441AE754-E0E1-4D90-BD8A-EF09F5106653Q33409285-48F1815D-E161-4ED0-863C-EC5A48D12497Q33410864-BA421A83-429A-451A-BD52-55DBF6514764Q33417773-B58A211F-5BA3-4C11-AFC9-4E4224350FF1Q33418352-55F35C12-FD8B-45D5-888A-395F370F5680Q33418553-9C0125EF-E886-49C5-8D74-A4217B324DF6Q33418645-A0858A04-76C7-4F0E-A288-672E1A6DC326Q33420881-C0CD447B-4CA0-4318-BC5D-BED804AAF7D9Q33421884-FC02C073-B85B-40F2-9B2B-9B297D870E87Q33441631-DA051486-2B00-43FF-85DA-8F749DE3F51BQ33443111-55CE9631-74F1-4976-A671-CF52DF12F34F
P2860
Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Deficient activity of von Will ...... otic thrombocytopenic purpura.
@ast
Deficient activity of von Will ...... otic thrombocytopenic purpura.
@en
type
label
Deficient activity of von Will ...... otic thrombocytopenic purpura.
@ast
Deficient activity of von Will ...... otic thrombocytopenic purpura.
@en
prefLabel
Deficient activity of von Will ...... otic thrombocytopenic purpura.
@ast
Deficient activity of von Will ...... otic thrombocytopenic purpura.
@en
P2093
P1433
P1476
Deficient activity of von Will ...... botic thrombocytopenic purpura
@en
P2093
P304
P407
P577
1997-05-01T00:00:00Z